Artelo Biosciences raises $310k via 12% bridge notes with default conversion feature

ARTELO BIOSCIENCES, INC.

Issued two 12% bridge notes totaling $350,300 principal ($237,300 Vanquish + $113,000 Boot) for net proceeds of $310,000 after $40,300 OID.
Notes mature Jan 15, 2027; company may prepay at any time with no penalty.
Upon default, notes can convert into common shares at the higher of $0.125 or 75% of the 10-day VWAP; conversion capped at 4.99% beneficial ownership per holder.
Proceeds used for general working capital; Company reimbursed Vanquish $10,000 in fees.
Securities issued under Regulation D, Section 4(a)(2); represented as accredited investors only.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ARTELO BIOSCIENCES, INC. entered into Vanquish Purchase Agreement with Vanquish Funding Group Inc. valued at $210,000.00 (effective 2026-03-12).

Action: entry
Agreement: equity purchase
Counterparty: Vanquish Funding Group Inc.
Value: $210,000.00
Effective: 2026-03-12

Exact text from the filing

On March 12, 2026, Artelo Biosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement, dated as of March 12, 2026 (the “Vanquish Purchase Agreement”), with Vanquish Funding Group Inc., a Virginia corporation (“Vanquish”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00 (the “Vanquish Note”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ARTELO BIOSCIENCES, INC. entered into Boot Purchase Agreement with Boot Capital LLC valued at $100,000.00 (effective 2026-03-12).

Action: entry
Agreement: equity purchase
Counterparty: Boot Capital LLC
Value: $100,000.00
Effective: 2026-03-12

Exact text from the filing

Additionally, on March 12, 2026, the Company entered into a Securities Purchase Agreement, dated as of March 12, 2026 (the “Boot Purchase Agreement” and together with the Vanquish Purchase Agreement, the “Purchase Agreements”), with Boot Capital LLC, a Delaware limited liability company (“Boot” and together with Vanquish , the “Buyers”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00 (the “Boot Note” and together with the Vanquish Note, the “Notes”).

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

ARTELO BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001640334-26-000475

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.